Washington-SANA
A recent study found that the Pfizer Bionic vaccine against Coronavirus works effectively against mutated strains of the virus that have recently appeared in Britain and South Africa and have spread around the world.
The American Fox News Network quoted the study conducted by scientists from several institutes as saying that "the American company Pfizer cooperated with researchers from the University of Texas to conduct laboratory tests to see if the new mutation that changes the shape of the proteins surrounding the virus impedes the capabilities of the vaccine, as the researchers used blood samples from 20 people." They received the Pfizer Bionic vaccine, and as a result, the antibodies succeeded in repelling the mutated virus.
Philip Dormitzer, chief scientific officer of Pfizer, described the results of the study as a very reassuring discovery, considering that this alarming mutation does not appear to be a problem in front of the vaccine, and that this research is only the beginning of the continuous monitoring of virus mutations to see if any of them affect the capabilities of the vaccine.
For his part, Richard Lessels, an infectious disease expert at the KwaZulu-Natal Innovation and Sequencing Platform, confirmed that it is unlikely that the mutation that occurred in the virus completely eliminates the effect of vaccines, adding that vaccines stimulate a very wide immune response and target different parts of the spike protein that envelops the virus and gives it the distinctive coronavirus Which mutates with its mutations.
In the midst of the efforts being made to develop anti-corona virus vaccines, the mutations caused scientists to worry that some vaccines may not be effective against the mutated Corona virus, the last of which was in Britain and South Africa and helped enhance the ability of the virus to spread faster, which increases the pressure on Health systems in countries where it is common, thus increasing deaths.